Specialties：Burns and wound repair surgery
Clinical Interests：
1.Treatment for critical burns and trauma;
2.Surgical treatment for diabetic foot;
3.Treatment for burn scars and keloids;
4.Surgical treatment for skin and soft tissue tumors;
5.Surgical treatment for acute and chronic wounds (pressure sores, iatrogenic wounds, etc.);
Education：
1.Chinese People's Liberation Army Medical College, Doctor of Medicine, 2014
Awards and Honors：
1. First prize of the Case Contest of the Burn Society of Guangdong Medical Association, 2017
2.Second Prize in the National Burn Case Competition, 2020
3.Third Prize in the National Burn Case Competition, 2019
4.Outstanding Case Award in the Case Competition of South China Division of Chinese Burn Association，2020
Professional memberships：
1. Correspondence Editor of “Chinese Critical Care Medicine”
Publications
1.Luo HM, Bian HN, Sun CW, Zheng SY, X B, Huang ZF, Liu ZA, Ma LH, Li HH, Lai W, Chen HD.Pyoderma gangrenosum secondary to caesarean section treated with negative pressure wound therapy and skin graft.Dermatol Ther,2021,34(2):e14858
2.Luo HM, Du MH, Lin ZL, Hu Q, Zhang L, Ma L, Wang H, Wen Y, Lv Y, Lin HY, Pi YL, Hu S, Sheng ZY. Ulinastatin Suppresses Burn-Induced Lipid Peroxidation and Reduces Fluid Requirements in a Swine Model. Oxid Med Cell Longev, 2013, 2013:904370.
3.Luo HM, Hu S, Zhou GY, Bai HY, Lv Y, Wang HB, Lin HY, Sheng ZY. The effects of ulinastatin on systemic inflammation, visceral vasopermeability and tissue water content in rats with scald injury. Burns, 2013, 39(5):916-922.
4.Luo HM, Hu S, Bai HY, Wang HB, Du MH, Lin ZL, Ma L, Wang H, Lv Y, Sheng ZY. Valproic Acid Treatment Attenuates Caspase-3 Activation and Improves Survival After Lethal Burn Injury in a Rodent Model. J Burn Care Res, 2013, 35(2):e93-8.
5.Luo HM, Du MH, Lin ZL, Zhang L, Ma L, Wang H, Yu W, Lv Y, Lu JY, Pi YL, Hu S, Sheng ZY. Valproic Acid Treatment Inhibits Hypoxia-Inducible Factor 1α Accumulation and Protects against Burn-Induced Gut Barrier Dysfunction in a Rodent Model. PLOS ONE, 2013, 8(10):e77523.
